[Plasmacytoid carcinoma. Five case reports of a rare variant of urothelial carcinoma].
Plasmacytoid carcinoma is a rare variant of urothelial carcinoma and is characterised by distinct histopathological and clinical characteristics. The incidence varies between 2.7% and 3.1% of all muscle-invasive urothelial carcinoma. It is an aggressive, high-grade tumor with poor prognosis. Negative E-cadherin expression seems to be important for exact diagnosis. Systemic chemotherapy of plasmacytoid carcinoma could lead to prolonged patient survival.
Keck
B
B
Urologische Universitätsklinik Erlangen-Nürnberg, Erlangen.
Stöhr
R
R
Goebell
P J
PJ
Fritsche
H M
HM
Wullich
B
B
Hartmann
A
A
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D018450:Disease Progression; D017809:Fatal Outcome; D014644:Genetic Variation; D006801:Humans; D008297:Male; D008875:Middle Aged; D010954:Plasmacytoma / Q000188:drug therapy / Q000235:genetics / Q000473:pathology*; D014571:Urologic Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000473:pathology*; D019459:Urothelium / Q000473:pathology*